Rosaceiform dermatitis associated with topical tacrolimus treatment - 24/04/13
Doi : 10.1016/j.jaad.2009.01.029
Shoko Fujiwara, MD, Yukari Okubo, MD ⁎ 
, Ryokichi Irisawa, MD, Ryoji Tsuboi, MD
, Ryokichi Irisawa, MD, Ryoji Tsuboi, MD Department of Dermatology, Tokyo Medical University, Tokyo, Japan
Reprint requests: Yukari Okubo, MD, Department of Dermatology, Tokyo Medical University, 6-7-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo 166-0023, Japan.Abstract |
We describe herein 3 patients who developed rosacea-like dermatitis eruptions while using 0.03% or 0.1% tacrolimus ointment for facial dermatitis. Skin biopsy specimens showed telangiectasia and noncaseating epithelioid granulomatous tissue formation in the papillary to mid dermis. Continuous topical use of immunomodulators such as tacrolimus or pimecrolimus should be regarded as a potential cause of rosaceiform dermatitis, although many cases have not been reported.
El texto completo de este artículo está disponible en PDF.Key words : rosaceiform dermatitis, tacrolimus treatment
Esquema
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
© 2009
American Academy of Dermatology, Inc.. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Vol 62 - N° 6
P. 1050-1052 - juin 2010 Regresar al número
Artículo precedente
- 595-nm long pulsed dye laser and 1450-nm diode laser in combination with intralesional triamcinolone/5-fluorouracil for hypertrophic scarring following a phenol peel
- Tracy M. Katz, Adrienne S. Glaich, Leonard H. Goldberg, Paul M. Friedman
- Drug samples in dermatology: Special considerations and recommendations for the future
- Ali Alikhan, Mary Sockolov, Robert T. Brodell, Steven R. Feldman
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?